Bloomage Biotechnology Corp. Ltd. engages in the production of hyaluronic acid, sodium hyaluronate bulk drugs, and medical supplements through fermentation. Its products include hyaluronic acid raw materials, medical terminal products, and functional skin care products. The company was founded on January 3, 2000 and is headquartered in Jinan, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company